ARS Pharmaceuticals (SPRY) Inventory (2024 - 2026)

ARS Pharmaceuticals has reported Inventory for 3 years, with the latest figure at $8.8 million in Q1 2026.

• Quarterly Inventory rose 21.28% year-over-year to $8.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $8.8 million (up 21.28% YoY) and the FY2025 annual result came in at $8.4 million, up 60.57% from the prior year.
• Inventory advanced to $8.8 million in Q1 2026 per SPRY's latest filing, from $8.4 million in the prior quarter.
• Over five years, Inventory peaked at $8.8 million in Q1 2026 and troughed at $715000.0 in Q3 2024.
• A 3-year average of $6.7 million and a median of $7.8 million in 2025 frame the typical range for Inventory.
• The sharpest annual moves came in 2025 and 2026: Inventory jumped 988.39% in 2025, then rose 21.28% in 2026.
• Over 3 years, Inventory stood at $5.2 million in 2024, then jumped by 60.57% to $8.4 million in 2025, then rose by 5.35% to $8.8 million in 2026.
• According to Business Quant data, Inventory over the past three periods registered $8.8 million, $8.4 million, and $7.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.